OTC
0.05USD
-0.01 (-10.86%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
25.5M
P/E
—
EPS
—
Beta
-0.70
52W range
0.0425-0.1435
Day range
0.05–0.06
Open
0.06
Prev close
0.06
Volume
1.6M
Avg volume
1.5M
Dividend
0.00
IPO
1998-09-02
https://www.globenewswire.com/news-release/2026/07/27/3333695/0/en/Vivos-Inc-OTCQB-RDGL-Reports-Second-Quarter-2026-Progress-and-Corporate-Update-Correction.html · 7/27/2026+0.80
https://www.defenseworld.net/2026/01/18/head-to-head-analysis-ofs-capital-nasdaqofs-and-advanced-medical-isotope-otcmktsrdgl.html · 1/18/2026+0.00
https://www.globenewswire.com/news-release/2025/09/29/3158036/0/en/Vivos-Inc-Board-Authorizes-Vivos-Inc-to-Establish-a-Corporate-Entity-in-India.html · 9/29/2025+0.60
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
